Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12371499 | Method of treating cancer using anti-AV8 antibodies | Kyle Steven Niessen, Dharmaraj Samuel, Charles R. Holst, Matthew Drever, Dean Sheppard +4 more | 2025-07-29 |
| 12371507 | CDCP1 antibodies and antibody drug conjugates | Lewis C. Cantley, Stephen P. Soltoff, Brooke Emerling, Georgios Poulogiannis, Cindy M. Hodakoski +9 more | 2025-07-29 |
| 11459385 | Anti-IL-2 antibodies and compositions and uses thereof | Natasha Crellin, Paul H. Bessette, Eleonora Trotta, Jeffrey A. Bluestone, Lauren K. Ely +1 more | 2022-10-04 |
| 11359024 | Anti-AVB8 antibodies and compositions and uses thereof | Kyle Steven Niessen, Dharmaraj Samuel, Charles R. Holst, Matthew Drever, Dean Sheppard +4 more | 2022-06-14 |
| 11066481 | Antibodies to coagulation factor XIa and uses thereof | Thomas Mikita, Lauren K. Ely, Huilan Gao, Yun Soo Kim, Tovo DAVID +1 more | 2021-07-20 |
| 10738113 | Anti-IL-2 antibodies and compositions and uses thereof | Natasha Crellin, Paul H. Bessette, Eleonora Trotta, Jeffrey A. Bluestone, Lauren K. Ely +1 more | 2020-08-11 |
| 10138298 | Anti-IL-2 antibodies and compositions and uses thereof | Natasha Crellin, Paul H. Bessette, Eleonora Trotta, Jeffrey A. Bluestone, Lauren K. Ely +1 more | 2018-11-27 |
| 8546307 | Triple tag sequence and methods of use thereof | Marina Roell, Daniel Bedinger | 2013-10-01 |
| 8546308 | Triple tag sequences and methods of use thereof | Marina Roell, Daniel Bedinger | 2013-10-01 |
| 8247185 | Conformation specific antibodies | Edward H. Cohen, Timothy A. Springer, Motomu Shimaoka | 2012-08-21 |
| 7927591 | Conformation specific antibodies | Edward H. Cohen, Timothy A. Springer, Motomu Shimaoka | 2011-04-19 |
| 7438890 | Binding peptides for carcinoembryonic antigen (CEA) | Robert Charles Ladner | 2008-10-21 |
| 6919424 | Binding peptides for carcinoembryonic antigen (CEA) | Robert Charles Ladner | 2005-07-19 |
| 6774209 | Binding peptides for carcinoembryonic antigen (CEA) | Robert Charles Ladner | 2004-08-10 |